ContraFect Corp to Host Development Update Call Transcript
Operator: Good morning and welcome to the ContraFect Corporation conference call. Currently, all participants are in listen-only mode. Please be advised that call is being recorded at the company's request.
I would now like to turn the call over to Mike Messinger, Chief Financial Officer. Please proceed.
Good morning everyone and welcome to ContraFect conference call to discuss our planned Phase 3 clinical trial for exebacase based on our successful end of Phase 2 meeting with the FDA.
With me today are Dr. Roger Pomerantz, ContraFect's Chief Executive Officer, Chairman and President; and Dr. Cara Cassino, our Chief Medical Officer and Executive Vice President of Research and Development. We will be hosting a question and answer session at the end of this call.
I also want to note a replay of this call will be available on our website. And we will post a new corporate presentation including all the new information regarding our Phase 3 plans on our website and filed in an 8-K later today
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |